Emerald Advisers, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Emerald Advisers, LLC

$2.23 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$83.14 - $145.99 $12.1 Million - $21.2 Million	-145,363 Reduced 45.94%	171,023 $24.9 Million
Q1 2022 Apr 29, 2022	BUY	$110.08 - $142.92 $6.57 Million - $8.53 Million	59,686 Added 23.25%	316,386 $37.5 Million
Q4 2021 Feb 02, 2022	BUY	$99.73 - $148.48 $4.96 Million - $7.38 Million	49,694 Added 24.01%	256,700 $35.4 Million
Q3 2021 Oct 28, 2021	BUY	$98.85 - $138.91 $20.5 Million - $28.8 Million	207,006 New	207,006 $28.8 Million
Q1 2021 Apr 29, 2021	SELL	$64.07 - $91.75 $5.23 Million - $7.49 Million	-81,616 Closed	0 $0
Q4 2020 Jan 29, 2021	SELL	$65.07 - $98.24 $7.6 Million - $11.5 Million	-116,836 Reduced 58.87%	81,616 $7 Million
Q3 2020 Oct 28, 2020	SELL	$59.04 - $77.95 $17.6 Million - $23.2 Million	-297,267 Reduced 59.97%	198,452 $12.9 Million
Q2 2020 Jul 28, 2020	SELL	$29.01 - $74.23 $2.46 Million - $6.31 Million	-84,960 Reduced 14.63%	495,719 $36.2 Million
Q1 2020 Apr 30, 2020	BUY	$27.51 - $57.29 $2.73 Million - $5.68 Million	99,185 Added 20.6%	580,679 $19.8 Million
Q4 2019 Jan 29, 2020	BUY	$40.86 - $57.65 $6.74 Million - $9.5 Million	164,848 Added 52.06%	481,494 $26.2 Million
Q3 2019 Oct 31, 2019	SELL	$37.38 - $49.47 $785,129 - $1.04 Million	-21,004 Reduced 6.22%	316,646 $13.2 Million
Q2 2019 Jul 31, 2019	SELL	$39.79 - $67.01 $10.2 Million - $17.1 Million	-255,143 Reduced 43.04%	337,650 $14.8 Million
Q1 2019 May 01, 2019	BUY	$34.52 - $53.29 $781,015 - $1.21 Million	22,625 Added 3.97%	592,793 $30.5 Million
Q4 2018 Jan 30, 2019	SELL	$29.75 - $42.9 $304,788 - $439,510	-10,245 Reduced 1.77%	570,168 $21.1 Million
Q3 2018 Oct 31, 2018	BUY	$32.79 - $43.0 $5.74 Million - $7.53 Million	175,049 Added 43.18%	580,413 $21.8 Million
Q2 2018 Jul 31, 2018	BUY	$23.62 - $42.29 $994,756 - $1.78 Million	42,115 Added 11.59%	405,364 $16 Million
Q1 2018 Apr 26, 2018	SELL	$22.49 - $34.56 $146,927 - $225,780	-6,533 Reduced 1.77%	363,249 $9.36 Million
Q4 2017 Feb 05, 2018	BUY	$20.44 - $35.56 $2.58 Million - $4.5 Million	126,455 Added 51.97%	369,782 $9.98 Million
Q3 2017 Oct 30, 2017	BUY	$23.54 - $38.21 $5.73 Million - $9.3 Million	243,327	243,327 $9.1 Million

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.

Account